← Open Payments lookup

ROBERTA KILBURN: Open Payments

NPI 1609203082 · AUSTIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,306 in 62 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $348 · 2025 $1,306

Food & beverage: $1,306
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.9$228
ABBVIE INC.10$222
Otsuka America Pharmaceutical, Inc.13$195
AstraZeneca Pharmaceuticals LP3$172
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$106
Teva Pharmaceuticals USA, Inc.5$98
Neurocrine BioSciences, Inc.5$85
Axsome Therapeutics, Inc.3$59
Janssen Pharmaceuticals, Inc2$41
Alkermes, Inc.2$29

Products named: FANAPT, VRAYLAR, BREZTRI, CAPLYTA, AUSTEDO XR, REXULTI, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across IN — which companies pay providers there.